An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
World-first technology to clear the heart of dangerous protein deposits
‘Desperate need for therapies for AL amyloid cardiomyopathy’